This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Harvard College, Massachusetts Eye and Ear Infirmary. Active years: 2021-2024.
Company Filing History:
4 out of 3,069 
4 out of 275 
Years Active: 2021-2024
Title: Margie Li: Innovator in Therapeutic Molecule Delivery
Introduction
Margie Li is a prominent inventor based in Cambridge, MA, known for her groundbreaking work in the field of therapeutic molecule delivery. With a total of 4 patents, she has made significant contributions to the understanding and treatment of genetic disorders, particularly those associated with hearing loss.
Latest Patents
Her latest patents include innovative methods for the efficient delivery of therapeutic molecules both in vitro and in vivo. One notable patent describes compositions for direct protein delivery into multiple cell types in the mammalian inner ear. These compositions are designed to deliver proteins, such as gene editing factors, aimed at correcting genetic mutations linked to deafness and related disorders. The methods focus on the intracellular delivery of these molecules to specific therapeutic targets, providing a promising avenue for restoring hearing in individuals affected by genetic deafness.
Another significant patent outlines compositions that induce cells of the inner ear to re-enter the cell cycle and proliferate. This includes the induction of hair cells to proliferate through the administration of a composition that activates the Myc and Notch pathways. Additionally, supporting cells can be induced to transdifferentiate into hair cells by inhibiting Myc and Notch activity or activating Atoh1. These methods represent a significant advancement in the treatment of hearing loss.
Career Highlights
Margie Li has worked with esteemed institutions such as Massachusetts Eye and Ear Infirmary and Harvard College. Her work at these organizations has allowed her to collaborate with leading experts in the field and contribute to cutting-edge research.
Collaborations
Throughout her career, Margie has collaborated with notable colleagues, including Zheng-Yi Chen and David R Liu. These partnerships have further enhanced her research and innovation in therapeutic delivery systems.
Conclusion
Margie Li's contributions to the field of therapeutic molecule delivery are invaluable, particularly in the context of genetic hearing loss. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.